Selected Grants
XPO1 and proteasome inhibition as a novel therapeutic combination in osteosarcoma
ResearchPrincipal Investigator · Awarded by The Paula Takacs Foundation For Sarcoma Research · 2026 - 2027Modeling tumor heterogeneity and therapy resistance in osteosarcoma using patient-derived organoids
ResearchPI-Fellow · Awarded by Hyundai Hope on Wheels · 2021 - 2024FACTOR Conference Travel Award
ConferenceFellow · Awarded by MIB Agents Inc. · 2022 - 2022External Relationships
- Karyopharm Therapeutics Inc
- Sutro Biopharma
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.